Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
about
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionDaclatasvir: A Review in Chronic Hepatitis C.Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015).Current trends in the treatment of hepatitis C: interventions to avoid adverse effects and increase effectiveness of anti-HCV drugs.Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice
P2860
Q26746563-7A867F06-84C3-4E98-9DC7-257122A25B0EQ30392100-D5DD2465-0035-4516-9D93-B43EDD42B562Q38779980-0F1ACF12-57ED-4145-9967-554091D9E00AQ39038238-6DDD8043-0391-4AA1-A89A-AA2C7864DA47Q39092871-2C36CC07-6FB6-4CF8-8786-91DF11469D2BQ39574126-4724C1AD-0AA5-4966-BE69-ACEBFAB5928BQ58737372-94A65FF1-FE12-4AA3-98BC-FE1A03B9DE28
P2860
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
@en
type
label
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
@en
prefLabel
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
@en
P2093
P2860
P356
P1476
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.
@en
P2093
Michael A Smith
Randolph E Regal
Rima A Mohammad
P2860
P356
10.1177/1060028015610342
P407
P577
2015-10-20T00:00:00Z